Document is current
Any future updates will be listed below
-
Authors
Cormio, Angelo https://orcid.org/0000-0002-6897-7040
Matsukawa, Akihiro https://orcid.org/0000-0002-3324-762X
Dematteis, Alessandro
Alfarhan, Ahmed R.
Miszczyk, Marcin https://orcid.org/0000-0002-4375-0827
Roessler, Navid
Alqahtani, Abdulrahman S.
Mancon, Stefano
Tsuboi, Ichiro https://orcid.org/0000-0002-3135-8262
Rajwa, Paweł https://orcid.org/0000-0003-4073-6584
Falagario, Ugo Giovanni https://orcid.org/0000-0002-1152-3005
Sanguedolce, Francesca
Busetto, Gian Maria https://orcid.org/0000-0002-7291-0316
Bettocchi, Carlo
Carrieri, Giuseppe
Cormio, Luigi
Galosi, Andrea Benedetto
D’Andrea, David https://orcid.org/0000-0003-1625-1077
Kimura, Takahiro https://orcid.org/0000-0002-5673-1553
Shariat, Shahrokh F. https://orcid.org/0000-0002-6627-6179
- License Information
-
More Information
Article History
Received: 18 November 2025
Revised: 4 March 2026
Accepted: 11 March 2026
First Online: 23 March 2026
Competing interests
: Shahrokh F. Shariat received the following: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda. Pawel Rajwa is a paid consultant/advisor of Janssen. The other authors declare no conflicts of interest associated with this manuscript.
